Detalhe da pesquisa
1.
Safety and Immunogenicity of Accelerated Heterologous Two-dose Ebola Vaccine Regimens in Adults With and Without HIV in Africa.
Clin Infect Dis
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38657084
2.
Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009.
Emerg Infect Dis
; 21(1): 23-31, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25529825
3.
Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial.
Lancet Infect Dis
; 20(4): 455-466, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31952923
4.
Botulinum neurotoxin vaccines: Past history and recent developments.
Hum Vaccin
; 5(12): 794-805, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19684478
5.
Development of a highly sensitive in vitro endothelial cell toxicity assay for evaluating ricin toxin A chain-based vaccines or therapeutics.
Toxicon
; 167: 152-161, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31207351
6.
Approach to Strain Selection and the Propagation of Viral Stocks for Venezuelan Equine Encephalitis Virus Vaccine Efficacy Testing under the Animal Rule.
Viruses
; 11(9)2019 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31480472
7.
Managing potential laboratory exposure to ebola virus by using a patient biocontainment care unit.
Emerg Infect Dis
; 14(6): 881-7, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18507897
8.
Botulinum neurotoxin vaccines: past, present, and future.
Crit Rev Immunol
; 27(4): 303-18, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-18197811
9.
Comparison of Aerosol- and Percutaneous-acquired Venezuelan Equine Encephalitis in Humans and Nonhuman Primates for Suitability in Predicting Clinical Efficacy under the Animal Rule.
Comp Med
; 68(5): 380-395, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30282570
10.
History of U.S. military contributions to the study of parasitic diseases.
Mil Med
; 170(4 Suppl): 17-29, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15916280
11.
TCRBV CDR3 diversity of CD4+ and CD8+ T-lymphocytes in HIV-infected individuals.
Hum Immunol
; 63(1): 51-60, 2002 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11916170
12.
Experience in the medical management of potential laboratory exposures to agents of bioterrorism on the basis of risk assessment at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID).
J Occup Environ Med
; 46(8): 801-11, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15300132
13.
Management guidelines for laboratory exposures to agents of bioterrorism.
J Occup Environ Med
; 46(8): 791-800, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15300131
14.
Risk of occupationally acquired illnesses from biological threat agents in unvaccinated laboratory workers.
Biosecur Bioterror
; 2(4): 281-93, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15650438
15.
A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome.
Vaccine
; 30(11): 1951-8, 2012 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-22248821
16.
Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study.
Vaccine
; 29(17): 3222-9, 2011 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-21354483
17.
An unusual inhalational exposure to Bacillus anthracis in a research laboratory.
J Occup Environ Med
; 46(4): 313-4, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15076646
18.
Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea.
Antiviral Res
; 81(1): 68-76, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18977392
19.
Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities.
Disaster Med Public Health Prep
; 1(2): 122-34, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18388640
20.
Laboratory exposures to staphylococcal enterotoxin B.
Emerg Infect Dis
; 10(9): 1544-9, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15498154